Susceptibility to colon carcinogenesis in C3H↔C57BL/6 chimeric mice reflects both tissue microenvironment and genotype

Cancer Letters

Volumn 239, Issue 2, 2006, Pages 205-211

  Tsukamoto, Tetsuya ^a   Yamamoto, Masami ^a   Fukami, Hiroko ^a   Yoshikawa, Akemi ^a   Sakai, Hiroki ^a   Hirata, Akihiro ^a   Kusakabe, Moriaki ^b,c   Tatematsu, Masae ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b Institute for Animal Reproduction   (Japan)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

1,2 dimethylhydrazine; Chimeric mouse; Colon carcinogenesis; Rodent strain differences; Susceptibility

Indexed keywords

1,2 DIMETHYLHYDRAZINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INCIDENCE; CANCER SUSCEPTIBILITY; CHIMERA; COLON CARCINOGENESIS; CONTROLLED STUDY; EMBRYO; FEMALE; GENOTYPE; MALE; MICROENVIRONMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; TUMOR LOCALIZATION;

ANIMALS; CHIMERA; COLONIC NEOPLASMS; DISEASE SUSCEPTIBILITY; GENOTYPE; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C3H; MICE, INBRED C57BL;

RODENTIA;

EID: 33745666495     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.08.004     Document Type: Article

References (29)

1. Wilmink A.B. Overview of the epidemiology of colorectal cancer. Dis. Colon Rectum 40 (1997) 483-493
2. Diwan B.A., Meier H., and Blackman K.E. Genetic differences in the induction of colorectal tumors by 1,2-dimethylhydrazine in bred mice. J. Natl. Cancer Inst. 59 (1977) 455-458
3. Evans J.T., Hauschka T.S., and Mittelman A. Differential susceptibility of four mouse strains to induction of multiple large-bowel neoplasms by 1,2-dimethylhydrazine. J. Natl. Cancer Inst. 52 (1974) 999-1000
4. Tatematsu M., Masui T., Fukami H., Yamamoto M., Nakanishi H., Inada K., et al. Primary monoclonal and secondary polyclonal growth of colon neoplastic lesions in C3H/HeN⇔BALB/c chimeric mice treated with 1,2- dimethylhydrazine immunohistochemical detection of C3H strain-specific antigen and simple sequence length polymorphism analysis of DNA. Int. J. Cancer 66 (1996) 234-238
5. Ponder B.A., and Wilkinson M.M. Direct examination of the clonality of carcinogen-induced colonic epithelial dysplasia in chimeric mice. J. Natl. Cancer Inst. 77 (1986) 967-976
6. Kusakabe M., Yokoyama M., Sakakura T., Nomura T., Hosick H.L., and Nishizuka Y. A novel methodology for analysis of cell distribution in chimeric mouse organs using a strain specific antibody. J. Cell Biol. 107 (1988) 257-265
7. Tatematsu M., Fukami H., Yamamoto M., Nakanishi H., Masui T., Kusakabe N., et al. Clonal analysis of glandular stomach carcinogenesis in C3H/HeN⇔BALB/c chimeric mice treated with N-methyl-N-nitrosourea. Cancer Lett. 83 (1994) 37-42
8. Tatematsu M., Masui T., Fukami H., Yamamoto M., Nakanishi H., Inada K., et al. Monoclonal development of squamous cell carcinomas from polyclonal papillary or nodular hyperplasias in the forestomach of C3H/HeN⇔BALB/c chimeric mice treated with N-methyl-N-nitrosourea or diethylnitrosamine. Carcinogenesis 17 (1996) 1365-1371
9. Tsukamoto T., Inada K., Fukami H., Yamamoto M., Tanaka H., Kusakabe M., et al. Mouse strain susceptibility to diethylnitrosamine induced hepatocarcinogenesis is cell autonomous whereas sex-susceptibility is due to the micro-environment: analysis with C3H⇔BALB/c sexually chimeric mice. Jpn. J. Cancer Res. 91 (2000) 665-673
10. Fujimitsu Y., Nakanishi H., Inada K., Yamachika T., Ichinose M., Fukami H., et al. Development of aberrant crypt foci involves a fission mechanism as revealed by isolation of aberrant crypts. Jpn. J. Cancer Res. 87 (1996) 1199-1203
11. Tsukamoto T., Kozaki K., Nishikawa Y., Yamamoto M., Fukami H., Inoue M., et al. Development and distribution of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced aberrant crypt foci in the rat large intestine. Jpn. J. Cancer Res. 90 (1999) 720-725
12. Tsukamoto T., Fukami H., Yamanaka S., Yamaguchi A., Nakanishi H., Sakai H., et al. Hexosaminidase-altered aberrant crypts, carrying decreased hexosaminidase alpha and beta subunit mRNAs, in colon of 1,2-dimethylhydrazine-treated rats. Jpn. J. Cancer Res. 92 (2001) 109-118
13. Yoshiki A., Sakakura T., and Kusakabe M. The mouse chimera during intrauterine stages: immunohistochemical analysis with the C3H strain-specific antibody. J. Histochem. Cytochem. 41 (1993) 1583-1590
14. Sakai H., Tsukamoto T., Yamamoto M., Shirai N., Iidaka T., Hirata A., et al. High susceptibility of nullizygous p53 knockout mice to colorectal tumor induction by 1,2-dimethylhydrazine. J. Cancer Res. Clin. Oncol. 129 (2003) 335-340
15. Delker D.A., Bammler T.K., and Rosenberg D.W. A comparative study of hepatic and colonic metabolic enzymes in inbred mouse lines before and after treatment with the colon carcinogen, 1,2-dimethylhydrazine. Drug Metab. Dispos. 24 (1996) 408-413
16. Rosenberg D.W., and Mankowski D.C. Induction of cyp2e-1 protein in mouse colon. Carcinogenesis 15 (1994) 73-78
17. Jacoby R.F., Hohman C., Marshall D.J., Frick T.J., Schlack S., Broda M., et al. Genetic analysis of colon cancer susceptibility in mice. Genomics 22 (1994) 381-387
18. Moen C.J., Groot P.C., Hart A.A., Snoek M., and Demant P. Fine mapping of colon tumor susceptibility (Scc) genes in the mouse, different from the genes known to be somatically mutated in colon cancer. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 1082-1086
19. Ruivenkamp C.A., van Wezel T., Zanon C., Stassen A.P., Vlcek C., Csikos T., et al. Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers. Nat. Genet. 31 (2002) 295-300
20. Ponder B.A., Wilkinson M.M., Wood M., and Westwood J.H. Immunohistochemical demonstration of H2 antigens in mouse tissue sections. J. Histochem. Cytochem. 31 (1983) 911-919
21. Schmidt G.H., Wilkinson M.M., and Ponder B.A. Cell migration pathway in the intestinal epithelium: an in situ marker system using mouse aggregation chimeras. Cell 40 (1985) 425-429
22. Ponder B.A., Schmidt G.H., Wilkinson M.M., Wood M.J., Monk M., and Reid A. Derivation of mouse intestinal crypts from single progenitor cells. Nature 313 (1985) 689-691
23. Gething M.J., and Sambrook J. Protein folding in the cell. Nature 355 (1992) 33-45
24. Michikawa Y., Baba T., Arai Y., Sakakura T., and Kusakabe M. Structure and organization of the gene encoding a mouse mitochondrial stress-70 protein. FEBS Lett. 336 (1993) 27-33
25. Michikawa Y., Baba T., Arai Y., Sakakura T., Tanaka M., and Kusakabe M. Antigenic protein specific for C3H strain mouse is a mitochondrial stress-70 protein. Biochem. Biophys. Res. Commun. 196 (1993) 223-232
26. Ohashi M., Oyanagi M., Hatakeyama K., Inoue M., and Kominami R. The gene encoding PBP74/CSA/motalin-1, a novel mouse hsp70, maps to mouse chromosome 18. Genomics 30 (1995) 406-407
27. Condamine H., Custer R.P., and Mintz B. Pure-strain and genetically mosaic liver tumors histochemically identified with the glucuronidase marker in allophenic mice. Proc. Natl. Acad. Sci. U.S.A. 68 (1971) 2032-2036
28. Lee G.H., Nomura K., Kanda H., Kusakabe M., Yoshiki A., Sakakura T., et al. Strain specific sensitivity to diethylnitrosamine-induced carcinogenesis is maintained in hepatocytes of C3H/HeN⇔C57BL/6N chimeric mice. Cancer Res. 51 (1991) 3257-3260
29. Yamamoto S., Tatematsu M., Yamamoto M., Fukami H., and Fukushima S. Clonal analysis of urothelial carcinomas in C3H/HeN⇔BALB/c chimeric mice treated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Carcinogenesis 19 (1998) 855-860